BELKIN Vision Overview
- Founded
-
2013
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Later Stage VC
- Investors
-
12
BELKIN Vision General Information
Description
Developer of noninvasive laser device intended to assist in the treatment of glaucoma. The company offers non-invasive, non-contact, instantaneous, painless, and automated devices offering laser therapy at the click of a button, enabling the medical community and patients to improve treatment outcomes.
Contact Information
Website
www.belkin-vision.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Primary Office
- 13 Gan Raveh Street
- Yavne 8122214
- Israel
+972 00-000-0000
BELKIN Vision Timeline
BELKIN Vision Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 20-Dec-2021 | 000.00 | Completed | Generating Revenue | ||
| 8. Later Stage VC (Series B) | 20-Jul-2020 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 7. Early Stage VC | 00000 | 00.000 | 00.000 | Completed | Clinical Trials - General | |
| 6. Early Stage VC (Series A) | 04-Jun-2017 | 00.00 | 00.00 | 00.000 | Completed | Clinical Trials - General |
| 5. Grant | 04-Jun-2017 | 00.000 | 00.00 | Completed | Clinical Trials - General | |
| 4. Seed Round | 01-Feb-2016 | 00.00 | 00.00 | Completed | Startup | |
| 3. Accelerator/Incubator | Completed | Startup | ||||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Grant | 01-Apr-2013 | $600K | Completed | Startup |
BELKIN Vision Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| B1 Preferred | 000,000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | ||
| B Preferred | 0,000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | ||
| A1 Preferred | 221,551 | $2.48 | $2.48 | 1x | $2.48 | 5.44% | ||
| A Preferred | 755,287 | $3.31 | $3.31 | 1x | $3.31 | 18.55% |
BELKIN Vision Patents
BELKIN Vision Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021311097-A1 | Automated capsulotomy | Pending | 19-Jul-2020 | ||
| AU-2020345067-A1 | Selective laser stimulation of corneal stem cells | Pending | 12-Sep-2019 | 000000000 | |
| EP-4028120-A1 | Selective laser stimulation of corneal stem cells | Pending | 12-Sep-2019 | 000000000 | |
| US-20220249861-A1 | Selective laser stimulation of corneal stem cells | Pending | 12-Sep-2019 | 0000000000 | |
| EP-3937867-A1 | Automated laser iridotomy | Pending | 13-Mar-2019 | A61F9/00825 |
BELKIN Vision Executive Team (9)
BELKIN Vision Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Andy Corley | Self | Chairman | 000 0000 |
| Da Liu | Self | Board Member | 000 0000 |
| Daria Lemann-Bluementhal | BELKIN Vision | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
| David Zigdon | RAD BioMed | Board Member | 000 0000 |
| Frank Lee Chen | Self | Board Member | 000 0000 |
BELKIN Vision Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
BELKIN Vision Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| European Innovation Council Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
| BioLight Life Sciences | Venture Capital | Minority | 000 0000 | 000000 0 | |
| China Resources Capital Management | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| C-Mer Eye Care | Corporation | Minority | 000 0000 | 000000 0 | |
| Santen Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |